Publications by authors named "E Dora"

Therapeutic vaccination can harness the body's cellular immune system to target and destroy cancerous cells. Several treatment options are available to eliminate pre-cancerous and cancerous lesions caused by human papillomaviruses (HPV), but may not result in a long-term cure. Therapeutic vaccination may offer an effective, durable, and minimally intrusive alternative.

View Article and Find Full Text PDF

Background: Polymicrobial pericarditis is an extremely rare and lethal form of pericarditis. Prompt initiation of appropriate antimicrobial treatment and pericardial drainage are crucial.

Case Summary: A 57-year-old immunocompromised male patient presented to the emergency department due to dyspnoea, chest pain, and fever lasting for 7 days.

View Article and Find Full Text PDF

As new SARS-CoV-2 variants continue to emerge and impact communities worldwide, next-generation vaccines that enhance protective mucosal immunity may have a significant impact on productive infection and transmission. We have developed recombinant non-replicating adenovirus serotype 5 (rAd5) vaccines delivered by mucosal administration that express both target antigen and a novel molecular adjuvant within the same cell. Here, we describe the immunogenicity of three unique SARS-CoV-2 rAd5 vaccine candidates and their efficacy following viral challenge in non-human primates (NHPs).

View Article and Find Full Text PDF

Successful therapy of mental disorders is very important in view of the high level of suffering of those affected. Since established pharmaceutical and psychotherapeutic approaches do not lead to the desired improvement in all cases, complementary or alternative treatment methods are intensively researched. Psilocybin-assisted psychotherapy seems particularly promising, and has been approved in the USA for larger clinical trials.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines a new mucosal vaccine strategy against SARS-CoV-2 variants, showing that intranasal and oral delivery of a non-replicating adenovirus-vectored vaccine can induce stronger immune responses compared to standard vaccinations.
  • - Hamsters vaccinated with the Wuhan variant vaccine before being exposed to the delta or omicron variants showed protection from weight loss and lung damage, reducing viral shedding significantly.
  • - The research suggests that mucosal vaccines might provide broader and more effective immunity against various SARS-CoV-2 variants, indicating they could be a promising approach to curtailing viral transmission and the emergence of new variants.
View Article and Find Full Text PDF